S
SkinLabo
Full-beauty brand Made-in-Italy with botanical extracts
About SkinLabo
Founded in Turin, Italy, in 2016 by Angelo Muratore, SkinLabo operates as a digitally native vertical brand in the personal products industry. Muratore, leveraging a background in luxury branding, digital marketing, and investment, aimed to make high-quality cosmetics more accessible. He identified a market gap for a direct-to-consumer (D2C) model that could offer premium Italian skincare without the associated high costs of traditional retail channels. This vision led to the creation of SkinLabo, backed by a team of co-founders with experience in cosmetics, e-commerce, and luxury goods.
The company's business model is exclusively direct-to-consumer, selling its products online to eliminate intermediary costs and maintain affordable pricing. Revenue is generated directly from the sale of its wide range of cosmetic products. This strategy allows SkinLabo to offer items at a price point that it claims is significantly lower than competitors for comparable quality. The company has secured substantial funding, raising a total of over €23 million through multiple rounds from investors including Vertis SGR, 8a+ Investimenti, Banca Generali, and Club degli Investitori. These investments have supported its rapid expansion across Europe and into the United States.
SkinLabo serves a broad consumer base in over 20 countries, with a significant and growing presence in Europe and the US. The core of its product strategy is a wide catalog of skincare items, all 100% developed and made in Italy. The product lines include cleansers, face and neck treatments, eye and lip care, and body care products, addressing various skin needs such as hydration, anti-aging, and blemish control. A key feature of its service is the provision of personalized beauty consultations via chat and phone, available 24/7 in 15 languages, connecting customers with a team of beauty experts for tailored advice. The products are formulated with a "clean beauty" approach, avoiding ingredients like parabens and mineral oils, while emphasizing high concentrations of effective active ingredients.
Source: Dealroom company dataKnowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| EARLY VC✓Equity / VC | Jan 2022 | $6.6M | $50M | 8A+ Investimenti SGR | ↗ |
| SERIES A✓Equity / VC | Sep 2021 | $10M | $40M | Vertis | — |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for SkinLabo is 1.4K monthly website visits, down 44% over the last three months. SkinLabo's team declined 2.2% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed4 investors entered at this stage
- WRWalter Ricciotti
- SGStefano Gaetani
Maire Investments
Luiss Alumni 4 Growth
Series A3 investors entered at this stage
Investors' club
Vertis
8A+ Investimenti SGR
Other known investors2 additional known investors
B Heroes
Roberto Zuccato
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about SkinLabo on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See SkinLabo’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







